CMG Pharmaceutical Co. Ltd (058820.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7058820002
CMG Pharmaceutical Co. Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 99.10 bn KRW | 105.23 bn KRW |
| Gross profit | 45.72 bn KRW | 60.93 bn KRW |
| Operating income | 2.51 bn KRW | -3.69 bn KRW |
| EBIT | 5.39 bn KRW | -8.67 bn KRW |
| Net income | 2.69 bn KRW | -10.08 bn KRW |
| Diluted EPS – continuing operations | 19.40 KRW | -68.16 KRW |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CMG Pharmaceutical Co. Ltd
CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013. CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.
More stocks
- Delta Technologies Nyrt (DELTA.BD)
- NP Life Sciences Health Industry Group Inc. (ACAT)
- d1000 Varejo Farma Participações S.A (DMVF3.SA)
- HARVARD BIOSCIENCE INC (HBIO)
- Energous Corp (WATT)
- Samil C&S Co Ltd (004440.KS)
- BATTALION OIL CORP (BATL)
- PLIANT THERAPEUTICS, INC. (PLRX)
- Abcourt Mines Inc. (ABI.V)
- Connect Biopharma Holdings Ltd (CNTB)
- Histeel (071090.KS)
- TSI Co. Ltd. (277880.KQ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.